Viewing Study NCT01578668


Ignite Creation Date: 2025-12-24 @ 5:56 PM
Ignite Modification Date: 2025-12-28 @ 12:30 AM
Study NCT ID: NCT01578668
Status: COMPLETED
Last Update Posted: 2015-01-26
First Post: 2012-04-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Erlotinib Plus Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases
Sponsor: Guangzhou Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module